Home › Stocks › AMLX

Amylyx Pharmaceuticals, Inc. (AMLX): insider buying, hedge funds & Congress trades

Amylyx Pharmaceuticals, Inc. (AMLX): 2 insider purchases in the last two years; 1 trade disclosed by members of Congress.

Insider buying

FiledInsiderSharesPriceValueType
Dec 23, 2025Firestone Karen
Director
8,100$12.45$100.8Kno history
Mar 24, 2025Zeiher Bernhardt G
Director
10,000$3.70$37.0Kno history

Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.

Get alerts for AMLX

Free account. Know when insiders, famous funds or Congress trade it.

Start free

Congress trades in AMLX

FiledMemberTypeAmount
Nov 16, 2022Christopher L. Jacobspurchase$1,001 - $15,000